Literature DB >> 76587

Alpha-fetoprotein (AFP) in benign liver disease. Evidence that normal liver regeneration does not induce AFP synthesis.

E Alpert, E R Feller.   

Abstract

One hundred sera samples, obtained during the early postoperative period from 11 patients after a partial hepatectomy, were assayed for alpha-fetoprotein (AFP). None were AFP-positive by radioimmunoassay, despite clinical and biochemical recovery associated with normal liver regeneration. AFP was elevated in 29% of patients with acute hepatitis, 34% of patients with chronic active hepatitis, and in 75% of patients with massive hepatic necrosis. The mechanism and significance of AFP elevations in some patients with acute and chronic hepatitis is uncertain but probably does not reflect normal liver regeneration.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 76587

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  36 in total

1.  Increased alpha-fetoprotein receptor in the serum of patients with early-stage breast cancer.

Authors:  R Moro; J Gulyaeva-Tcherkassova; P Stieber
Journal:  Curr Oncol       Date:  2012-02       Impact factor: 3.677

Review 2.  Biomarkers: evaluation of screening for and early diagnosis of hepatocellular carcinoma in Japan and china.

Authors:  Peipei Song; Jianjun Gao; Yoshinori Inagaki; Norihiro Kokudo; Kiyoshi Hasegawa; Yasuhiko Sugawara; Wei Tang
Journal:  Liver Cancer       Date:  2013-01       Impact factor: 11.740

3.  Alpha-fetoprotein-producing carcinoma of the gallbladder.

Authors:  M Watanabe; Y Hori; T Nojima; H Kato; K Taketa; S Isogawa; K Yokoyama; S Nakagawa
Journal:  Dig Dis Sci       Date:  1993-03       Impact factor: 3.199

4.  Human liver regeneration after major hepatic resection. A study of normal liver and livers with chronic hepatitis and cirrhosis.

Authors:  N Nagasue; H Yukaya; Y Ogawa; H Kohno; T Nakamura
Journal:  Ann Surg       Date:  1987-07       Impact factor: 12.969

5.  Ultrasonography and alpha-fetoprotein in diagnosis of hepatocellular carcinoma in cirrhosis.

Authors:  A Maringhini; M Cottone; E Sciarrino; M P Marcenó; F La Seta; G Fusco; F Rinaldi; L Pagliaro
Journal:  Dig Dis Sci       Date:  1988-01       Impact factor: 3.199

6.  Immunoelectron microscopic observation of alpha-fetoprotein synthesis in human non-malignant liver tissues using immunoperoxidase methods.

Authors:  S Kinoyama; G Yamada; H Okushin; H Mimura; T Kobayashi; T Tsuji
Journal:  Gastroenterol Jpn       Date:  1988-08

7.  Serum alpha-fetoprotein in nonneoplastic liver diseases.

Authors:  J R Bloomer
Journal:  Dig Dis Sci       Date:  1980-04       Impact factor: 3.199

8.  Decrease in alpha-fetoprotein levels predicts reduced incidence of hepatocellular carcinoma in patients with hepatitis C virus infection receiving interferon therapy: a single center study.

Authors:  Yukio Osaki; Yoshihide Ueda; Hiroyuki Marusawa; Jun Nakajima; Toru Kimura; Ryuichi Kita; Hiroki Nishikawa; Sumio Saito; Shinichiro Henmi; Azusa Sakamoto; Yuji Eso; Tsutomu Chiba
Journal:  J Gastroenterol       Date:  2011-11-23       Impact factor: 7.527

Review 9.  Does Hepatocellular Carcinoma Surveillance Increase Survival in At-Risk Populations? Patient Selection, Biomarkers, and Barriers.

Authors:  Lisa X Deng; Neil Mehta
Journal:  Dig Dis Sci       Date:  2020-12       Impact factor: 3.199

10.  Circulating intercellular adhesion molecule 1 predicts non-specific elevation of alpha 1-fetoprotein.

Authors:  E Falleti; C Fabris; M Pirisi; G Soardo; D Vitulli; P Toniutto; E Bartoli; N Bortolotti; F Gonano
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.